Waverton Investment Management Ltd grew its stake in Becton Dickinson and Co (NYSE:BDX) by 9.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 432,388 shares of the medical instruments supplier’s stock after acquiring an additional 35,776 shares during the period. Becton Dickinson and accounts for about 5.4% of Waverton Investment Management Ltd’s investment portfolio, making the stock its 6th biggest position. Waverton Investment Management Ltd owned approximately 0.16% of Becton Dickinson and worth $92,557,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other large investors have also recently modified their holdings of BDX. Vanguard Group Inc. boosted its holdings in shares of Becton Dickinson and by 8.5% in the second quarter. Vanguard Group Inc. now owns 17,255,948 shares of the medical instruments supplier’s stock valued at $3,366,809,000 after buying an additional 1,353,780 shares during the period. State Street Corp boosted its holdings in Becton Dickinson and by 3.5% during the second quarter. State Street Corp now owns 10,270,221 shares of the medical instruments supplier’s stock worth $2,003,834,000 after purchasing an additional 342,873 shares during the last quarter. Northern Trust Corp boosted its holdings in Becton Dickinson and by 4.0% during the second quarter. Northern Trust Corp now owns 2,813,937 shares of the medical instruments supplier’s stock worth $549,028,000 after purchasing an additional 106,966 shares during the last quarter. Fiera Capital Corp boosted its holdings in Becton Dickinson and by 7.1% during the second quarter. Fiera Capital Corp now owns 2,782,146 shares of the medical instruments supplier’s stock worth $542,825,000 after purchasing an additional 183,372 shares during the last quarter. Finally, Fundsmith LLP boosted its holdings in Becton Dickinson and by 0.3% during the second quarter. Fundsmith LLP now owns 2,302,590 shares of the medical instruments supplier’s stock worth $449,258,000 after purchasing an additional 5,977 shares during the last quarter. 75.54% of the stock is owned by hedge funds and other institutional investors.
Becton Dickinson and Co (NYSE BDX) traded up $0.83 on Wednesday, hitting $228.54. 1,746,100 shares of the stock were exchanged, compared to its average volume of 1,676,570. Becton Dickinson and Co has a one year low of $169.19 and a one year high of $230.12. The company has a current ratio of 5.58, a quick ratio of 5.03 and a debt-to-equity ratio of 1.44. The firm has a market cap of $52,930.00, a P/E ratio of 49.15, a P/E/G ratio of 1.78 and a beta of 1.07.
The firm also recently announced a quarterly dividend, which was paid on Friday, December 29th. Investors of record on Friday, December 8th were given a dividend of $0.75 per share. The ex-dividend date was Thursday, December 7th. This is an increase from Becton Dickinson and’s previous quarterly dividend of $0.73. This represents a $3.00 annualized dividend and a yield of 1.31%. Becton Dickinson and’s dividend payout ratio (DPR) is currently 64.52%.
BDX has been the topic of several analyst reports. Zacks Investment Research raised shares of Becton Dickinson and from a “hold” rating to a “buy” rating and set a $240.00 price target on the stock in a research report on Wednesday, January 3rd. Deutsche Bank set a $260.00 price objective on shares of Becton Dickinson and and gave the company a “buy” rating in a research report on Friday, December 29th. Argus increased their price objective on shares of Becton Dickinson and to $235.00 and gave the company a “buy” rating in a research report on Thursday, December 14th. They noted that the move was a valuation call. Stifel Nicolaus reissued a “buy” rating and issued a $245.00 price objective on shares of Becton Dickinson and in a research report on Friday, November 3rd. Finally, Morgan Stanley raised their price target on shares of Becton Dickinson and from $205.00 to $245.00 and gave the stock an “equal weight” rating in a research report on Friday, November 3rd. Five investment analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus target price of $230.20.
ILLEGAL ACTIVITY WARNING: “Becton Dickinson and Co (NYSE:BDX) Holdings Boosted by Waverton Investment Management Ltd” was posted by BBNS and is the property of of BBNS. If you are reading this article on another domain, it was illegally copied and republished in violation of U.S. & international copyright laws. The legal version of this article can be accessed at https://baseballnewssource.com/markets/becton-dickinson-and-co-bdx-shares-bought-by-waverton-investment-management-ltd/1823346.html.
About Becton Dickinson and
Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.
Receive News & Ratings for Becton Dickinson and Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and and related companies with MarketBeat.com's FREE daily email newsletter.